Regenasome Pty Ltd
PrivateLast Round
Pre Seed
Sep 18, 2025
Total Funding Raised
$830,000
Company Overview
Regenasome Pty Ltd operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Pre Seed round in September 2025.
Regenasome Pty Ltd is a biotechnology company that develops exosome-based therapies for the treatment of fibrotic and lung diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenasome Pty Ltd Comparables
Compare Regenasome Pty Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExoCoBio | 72% | |
| VivaZome Therapeutics | 61% | |
| Aegle Therapeutics Corp | 55% |
For institutional investors. Book with your work email.
Regenasome Pty Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Sep 18, 2025 | ||||
| Debt | May 1, 2025 | ||||
| Pre Seed | Oct 22, 2024 |
For institutional investors. Book with your work email.
Regenasome Pty Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leave a Nest Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2025
$130K round led by Leave a Nest Capital
For institutional investors. Book with your work email.
Regenasome Pty Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regenasome Pty Ltd's valuation, stock price, and market status.
Is Regenasome Pty Ltd a public or private company?
Regenasome Pty Ltd is a private company.
What is the current stock price of Regenasome Pty Ltd?
Regenasome Pty Ltd is a private company, so its shares have no public market price. Caplight tracks Regenasome Pty Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regenasome Pty Ltd worth (valuation)?
Valuation information for Regenasome Pty Ltd is not publicly available.
Can I buy Regenasome Pty Ltd stock?
Regenasome Pty Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regenasome Pty Ltd's last funding round?
Regenasome Pty Ltd's most recent funding round was Pre Seed on September 18, 2025.
Who are the main investors in Regenasome Pty Ltd?
Key investors in Regenasome Pty Ltd include Leave a Nest Capital.
Will Regenasome Pty Ltd IPO soon?
No public IPO plans have been announced for Regenasome Pty Ltd.
How can I track Regenasome Pty Ltd secondary market activity?
Caplight tracks bids, offers, and trades in Regenasome Pty Ltd's shares on secondary markets.